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Abstract  
Aims 
Attendance for screening to detect sight-threatening diabetic retinopathy is suboptimal. 
Identifying the theoretical determinants (barriers and enablers) of attendance behaviour can 
inform interventions to improve attendance. We aimed to identify and synthesise studies 
reporting modifiable barriers/enablers associated with retinopathy screening attendance in 
people with type 1 or type 2 diabetes, and identify those most likely to influence attendance. 
Methods  
We searched MEDLINE, EMBASE, PsycINFO, Cochrane Library and sources of grey 
literature for quantitative and qualitative studies to February 2017. Data (i.e. participant 
quotations, interpretive summaries, survey results) reporting barriers/enablers were extracted 
and deductively coded into domains from the Theoretical Domains Framework; with domains 
representing categories of theoretical barriers/enablers proposed to mediate behaviour change. 
Inductive thematic analysis was conducted within domains to describe the role each domain 
plays in facilitating or hindering screening attendance. Domains that were more frequently 
coded and for which more themes were generated were judged more likely to influence 
attendance.  
Results  
Sixty-nine primary studies were included. We identified six theoretical domains 
(‘environmental context and resources’ [75% of included studies]; , ‘social influences’ [51%], 
‘knowledge’ [50%], ‘memory, attention, decision processes’ 50%], ‘beliefs about 
consequences’ [38%] and ‘emotions’ [33%]) as key mediators of diabetic retinopathy 
screening attendance behaviour. Specific barriers/enablers populating these domains were 
identified at multiple levels. For example, some people with diabetes confused screening with 
routine eye care; recommendations by a healthcare professional facilitated screening 
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attendance; at the system level, inaccurate registers were reported; and community-level media 
coverage was an enabler.  
Conclusions  
Across a variety of contexts, we found common barriers and enablers to retinopathy screening 
that are important to target by interventions aiming to increase screening attendance. 
 
Keywords; Diabetic retinopathy, Screening attendance, Barriers, Enablers, Facilitators, 
Theoretical Domains Framework.  
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Introduction  
Diabetic retinopathy is a leading cause of severe sight loss in people of working age1,2. 
Although effective treatments are available3, their success is dependent on early detection and 
timely referral. Diabetic retinopathy screening effectively reduces risk of sight loss; however, 
screening attendance is consistently below recommended levels4-6. 
 
Interventions that target screening behaviour are more likely to be effective if they target the 
determinants (barriers and enablers) of screening attendance. The Theoretical Domains 
Framework of behaviour proposes 14 ‘theoretical domains’ for identifying and categorising 
barriers/enablers (e.g. ‘knowledge,’ ‘beliefs about consequences,’ ‘social influences’). Each 
domain represents a set of related constructs that may mediate behaviour change. For example, 
the ‘social influences’ domain includes the constructs ‘social support,’ ‘group norms’ and 
‘social comparison7.’ The framework thus provides a theory-driven basis for investigating the 
potentially wide-ranging barriers/ enablers of behaviour change.
 
 
The Theoretical Domains Framework has been applied in numerous studies to systematically 
identify and characterise barriers/enablers to implementation across various clinical contexts, 
primarily through interview and survey studies. More recently the framework has been applied 
in systematic reviews of barriers/enablers, as a coding framework for data synthesis e.g. in a 
study of barriers to the optimal clinical management of stroke8. Identifying barriers/ enablers 
in the literature, framing these in terms of theoretical domains, and identifying their likely 
importance for screening attendance, are steps that might explain why some interventions are 
more effective than others. This would enable intervention designers to optimise interventions 
by ensuring that they target the likely determinants of screening attendance. 
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We aimed to gain an understanding of retinopathy screening attendance behaviour by 
identifying the theoretical determinants of screening attendance. 
 
The specific objectives were to:  
• Identify the published and grey literature reporting perceived barriers and enablers associated 
with screening attendance 
• Extract reported barriers/enablers and categorise these according to Theoretical Domains 
Framework domains  
• Apply pre-specified criteria to identify the likely importance of Theoretical Domains 
Framework  domains in influencing screening attendance.  
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Methods  
A detailed protocol for this review has been published9 and registered in PROSPERO 
(CRD42016032990). In brief, we included studies reporting primary data relating to modifiable 
factors that might hinder or facilitate retinopathy screening attendance. We included studies 
reported in English, conducted between January 1990 and February 2017, basing the lower 
date limiter on the publication of the St Vincent Declaration (“Diabetes care and research in 
Europe: the Saint Vincent declaration.,” 1990), which set a target to reduce new blindness in 
Europe by one third or more, as this is arguably the catalyst for the development of diabetic 
retinopathy screening programmes worldwide. Studies were excluded if the reported barrier to 
screening was non-modifiable e.g. relating to age, gender, socioeconomic status or duration of 
diabetes. 
Six bibliographic databases were searched to identify the published literature [MEDLINE, 
EMBASE, PsycINFO, Web-of-Science, CENTRAL in the Cochrane Library, Proquest]. An 
example search strategy for MEDLINE is provided in supplementary Appendix A. Grey 
literature databases were also searched, e.g. OpenGrey, and PsycEXTRA, alongside a Google 
search engine search using the terms: “diabetic retinopathy” AND screening AND [barrier* 
OR “facilitat* OR enable]. We limited the Google search to the first 15 pages. Reference lists 
of included studies were screened for additional studies. Following de-duplication, one 
member of the research team (EGR) screened all identified titles and abstracts against the 
inclusion/exclusion criteria. A second review author (FL) screened approximately 10% of the 
titles and abstracts to check reliability. Since the interrater agreement was substantial (Cohens 
Kappa= xx) it was judged unlikely that double checking further papers would have materially 
impacted on the level of agreement. Full-text copies of potentially eligible studies were 
obtained and a final decision was made on inclusion by consensus amongst the review team.  
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Data extraction and analysis  
We followed analysis methods used in previous studies applying the Theoretical Domains 
Framework to interview transcripts from semi-structured interviews10. These methods follow 
a combined content and framework analysis approach (Figure 1) involving four steps: 1) data 
extraction; 2) deductive analysis (Theoretical Domains Framework coding); 3) inductive 
analysis (thematic synthesis); and 4) identifying important domains. 
 
FIGURE 1 HERE 
 
Step 1: Data extraction.  
One review author (EGR) identified and extracted data reporting participants’ (e.g. people 
with diabetes and/or healthcare professionals (HCPs)) perceptions of modifiable barriers/ 
enablers to screening attendance. A second reviewer (JGL) checked the accuracy of data 
extraction on a random 20% sample of included studies. Extracted data included participant 
quotations from qualitative studies, quantitative findings from questionnaire and survey 
studies and authors’ interpretive descriptions and summaries of results. Predictors of and 
associations with attendance/non-attendance reported in quantitative studies were also 
extracted. 
Step 2a. Pilot coding exercise 
In order to practise coding extracted data into theoretical domains, three pilot transcripts were 
coded independently by two reviewers (EGR and FL). Any discrepancies were discussed until 
agreement was reached. The pilot transcripts were used to develop a Theoretical Domains 
Framework codebook (the content of the codebook is provided in supplementary Appendix B). 
Step 2b. Theoretical Domains Framework coding 
9 
 
One review author (EGR) coded the data extracted from all remaining studies. Extracted data 
was coded according to which domain they were judged to represent, guided by the  codebook. 
Using a process that was arguably more robust than the 20% double coding specified in the study 
protocol9, three members of the review team (EGR, FL, JJF) met to verify and discuss every extracted 
data item to assess the domain-level coding, in the context of step 3 (described below).  
Step 3: Thematic synthesis  
In line with a framework analysis approach, step 3 focussed on sifting and sorting the data 
within each domain to thematically synthesise and identify emerging content themes. One 
review author (EGR) grouped together similar data relating to perceived barriers/enablers to 
screening attendance, for each of the 14 domains. Theme labels (describing broad content 
themes) and, where appropriate, sub-theme labels (nested within the themes, describing more 
detailed content) were then generated for each cluster of similar data to express these shared 
views. Three members of the review team (EGR, FL, JJF) met to verify and discuss every extracted 
data item to assess their agreement with: 1) grouping of extracted data; 2) assigned theme and 
sub-theme labels; and 3) whether the theme was appropriately allocated to the given domain. 
Disagreements were discussed until consensus was reached and theme groups, labels and 
allocation of domains were revised accordingly.  
 
Additionally, EGR assigned the data within the themes as either representing barriers or 
enablers to screening attendance. This was usually clear from the original papers as it was 
either reported in a table titled ‘barriers to’ or ‘enablers to screening’ attendance or interpreted 
as one or the other by the study author. Each theme/sub-theme was then classified as: 1) a 
barrier theme if the data within it related to barriers only (e.g. receiving insufficient notice of 
appointments); 2) an enabler theme if the data within it related to enablers only (e.g. support 
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from local community groups/networks) and 3) both a barrier and an enabler theme if it related 
to both (e.g. [In]flexibility of choice of times/dates of appointments). 
 
Step 4: Identifying important domains 
Each domain identified in step 2 was reviewed against an established set of three ‘importance 
criteria’11 to determine which domains were likely to be important for influencing screening 
attendance: (1) frequency (number of studies that identified each domain; (2) elaboration 
(number of themes and sub-themes) within each domain; and (3) ‘expressed importance’ 
(either a statement from the authors’ interpretation or direct quotes from study participants 
expressing importance).  
 
Quality assessment 
One review author (EGR) rated included studies using items from the Critical Appraisal Skills 
Programme Qualitative Checklist (CASP) (http://www.casp-uk.net/casp-tools-checklists) and 
the Mixed Methods Appraisal Tool (MMAT) 
(https://www.mcgill.ca/familymed/research/projects/mmat). Mixed-methods studies were 
appraised using both quantitative and qualitative appraisal tools. A second review author (JL) 
independently assessed a random sample of studies (20%). Agreement was not formally 
assessed as only minor differences of opinion regarding study quality were identified. These 
were resolved by discussion.  
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Results  
Study Characteristics  
After removing duplicates we screened 3,194 studies and reviewed 234 full text articles. We 
excluded 165 studies with reasons and included 69 studies that met our inclusion criteria (see 
Figure 2 for the PRISMA flow diagram). Table 1 presents an overview of the characteristics 
of included studies. Full details are provided in supplementary Appendix C. 
 
FIGURE 2 HERE 
TABLE 1 HERE 
 
Quality of included studies  
Overall, studies were judged to be at low (46.7%), medium (8.3%) or unclear (45%) risk of 
bias (see supplementary Appendix D). 
 
Deductive analysis  
In total, 737 units of data were extracted: 468 qualitative (167 quotations from study 
participants and 301 from authors’ conclusions) and 269 quantitative (e.g., percentages of 
participants agreeing with a questionnaire item, or odds ratios).  
 
Reported barriers were identified in all but one of the theoretical domains (‘skills’). Enablers 
were identified in all but two domains (‘beliefs about capabilities’ and ‘skills’). Overall there 
were almost twice as many themes/sub-themes identified as barriers only than as enablers only 
(61 vs 34). Twenty-one themes/subthemes represented both barriers/enablers. Table 2 reports 
the frequencies of barriers/enablers identified within each domain. 
 
TABLE 2 HERE  
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Inductive analysis 
Supplementary Appendix E presents all themes and sub-themes identified within each domain, 
alongside frequencies, relevant studies and sample quotes. A narrative description of the 
themes, within domains, is presented below, for the domains that were identified as high in 
importance. 
 
Importance of Theoretical Domains Framework domains 
Domain frequency 
The data units were coded most frequently into the following domains: 1) environmental 
context and resources (52 studies); 2) social influences (35 studies); (3) knowledge (35 
studies); 4) memory, attention and decision processes (34 studies); 5) beliefs about 
consequences (26 studies); and 6) emotions (23 studies).  
 
Level of elaboration 
Approximately 82% of themes/sub-themes relating to barriers and 69% relating to enablers 
were captured in the same six theoretical domains (Table 2, columns 2 & 3). Table 3 (columns 
3 & 4) lists the numbers of themes and sub-themes identified within each domain. 
 
Rank order of domain importance  
In Table 3, the fourteen theoretical domains are presented in rank order. In general, there was 
good convergence between frequency (number of studies in which the domain was evident) 
and elaboration (number of themes and sub-themes based on the inductive analysis).  
 
TABLE 3 HERE 
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Expressed importance 
Study authors’ interpretations of the study findings (e.g., in Discussion sections) articulating 
specific beliefs as important influences, also provided evidence of the importance of barriers/ 
enablers.  Quotations expressing importance are presented in supplementary Appendix G 
alongside the domain they were judged to represent.  For example, the following quotes from 
included studies represent expressed importance for the domain: 1) ‘environmental context and 
resources’ (“Getting to and from screening appointment was important pragmatically for many 
patients, who had to overcome a range of issues”) and 2) ‘beliefs about consequences’ (“The 
main reason for refusal was the retinal photos taken might worsen sight”). The number of 
studies that identified each domain through expressed importance was counted: the higher the 
count, the higher the expressed importance. On this basis, important domains were: 
environmental context and resources (21 studies); knowledge (19 studies); memory attention 
and decision processes (12 studies); social influences (10 studies); beliefs about consequences 
(6 studies); and emotions (5 studies). This list corresponds well with the list of six domains of 
high importance identified by the importance criteria ‘frequency’ and ‘elaboration’ (Table 3).  
 
TABLE 3 HERE 
 
In summary, there was good convergence between all three criteria for identifying the 
importance of six theoretical domains, suggesting these domains are likely to be key mediators 
of screening attendance behaviour.  
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Thematic synthesis for domains identified as having high importance 
The content themes in the domains that were identified as potentially important factors 
influencing screening attendance are described in further detail in the sections below, with 
example references.  
 
Environmental context and resources (52 studies) 
Theme: Accessibility to the screening clinic (31 studies) 
This theme was identified by both people with diabetes and HCPs. “Accessibility” included 
issues with transportation (e.g. lack/cost/poor quality) and distance to the screening clinic. In 
one correlational study, in an urban area, attendance was associated with living within an eight-
mile radius of the screening facility and with access to public transportation12. In several 
studies, distance from home to screening services was thought to improve attendance13,14. In 
two studies, mobile screening units were associated with higher attendance, compared to 
screening appointments at high street optometrists15,16. 
 
Theme: Time (competing demands) (29 studies) 
People with diabetes often cited ‘time constraints’ as a barrier to attendance. Competing 
demands on their time were due to: work commitments (e.g. finding it hard to take time off 
work); family responsibilities (e.g., childcare); and clashes with other immoveable life events 
(e.g., holidays, religious/cultural activities. One HCP commented that: “People go away…to 
the Caribbean, Africa, Asia, Pakistan, India… and because they’re away they’re not going to 
get their screening done”17. 
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Themes: Financial concerns (27 studies) and consequences of private insurance (5 studies) 
Financial concerns, such as the cost of the eye exam/care and the cost or lack of insurance were 
common, especially in the US studies18,19 but attendance was sometimes not influenced by 
insurance20. Self-employed or casual employees reported costs owing to lost income when they 
took time off work to attend screening appointments21,22. 
 
Theme: Scheduling appointment issues (19 studies) 
Problems with scheduling appointments, including a long wait to receive an appointment and 
inability to get an appointment, were barriers to attendance. Three UK studies mentioned that 
people with diabetes had not received an invitation or had been given insufficient notice22-24. 
Some expressed a preference for appointment flexibility but, in one study, older people with 
diabetes preferred fixed appointments25. Centrally-allocated appointments were perceived by 
some HCPs to be problematic14, as they undermined their own attempts to bring their patients 
to the clinic17.  
 
Theme: Time (service issues) (9 studies) 
Long wait times on the day of the appointment and lengthy appointments were barriers to 
attendance. For multiple appointments some reported ‘waiting around’ all day26, while long 
appointments could be especially problematic for people with diabetes, due to lengthy food 
abstinence27. 
 
Theme: Referral issues (8 studies) 
The absence of a referral was a substantial problem for some. In one UK study, a person with 
diabetes who normally attends her screening appointments had attempted to access screening 
through her GP practice but was refused as she was in temporary accommodation waiting to 
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be rehoused27. In some countries, people with diabetes were not referred because there was no 
available eye doctor13. Inaccurate or incomplete registers could also result in lack of 
referral14,17. 
 
Theme: Specialist diabetes services and staff (6 studies) 
The integration of specialist diabetes services or ‘one-stop-shops’ was viewed as beneficial: 
“if the eye appointment was on the same day as the DM [Diabetes Mellitus] appointment I 
would definitely attend”13. However, inflexible or incompatible administration systems were a 
problem17.  Having a specialist practice nurse was associated with increased attendance in two 
studies15,28. 
 
Social influences (Total = 35 studies)  
Theme: Doctor-patient communication (25 studies)  
Doctor-patient communication was discussed in many studies. A recommendation by the HCP 
to attend screening was an enabler29,30 and having received a recommendation from a 
healthcare provider to attend screening was associated with attendance31-33. The absence of a 
HCP recommendation was a barrier in other studies34-37. Some people with diabetes reported 
lack of information provision from their healthcare providers26,29,38, especially at the point of 
diagnosis. 
 
Language and/or communication style, especially for people whose first language was not the 
same as the HCP’s, was a barrier. In some studies people with diabetes reported language 
difficulties as the primary reason for not attending screening appointments23. In one study a 
participant “didn’t understand her physician and was too intimidated to ask him to slow down 
when conversing” and was unaware of the recommendation to attend21. In some studies, 
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participants felt that systems were in place to overcome this barrier (e.g., provision of 
interpreters and accompanying family members)14,27,39. However, HCPs noted that 
accompanying relatives might not have the language skills needed to interpret correctly14. 
Theme: Trust in doctors (5 studies) 
Advice and recommendations from doctors were perceived to be an enabler in several studies 
and some people with diabetes were content to rely on their doctor’s advice regarding 
screening29. However, in one study it was reported that a small number did not trust doctors30 
and another reported that low confidence in doctors was more common in non-attenders than 
attenders33. Perceived discrimination in the healthcare system was associated with longer time 
periods between screening visits40. Conversely, a study of Canadian Aboriginals reported that 
a culturally sensitive community-based clinic overcame such barriers21. 
 
Theme: Presence or absence of support from family members (N =11) 
Family support, both practical (e.g. providing transport to the clinic) and emotional (e.g. 
encouragement, offering gentle reminders), was an enabler29,30, and its absence was a 
barrier41,42. Family support was especially important in communities that traditionally rely on 
their family members to look after them39 or when the person had a physical disability37. 
 
Theme: Encouragement/support from local community groups/networks (3 studies) plus media 
attention and coverage (4 studies) 
Community-based programmes fostered trust and support21 and provided information39,43. 
Furthermore, local media (TV, newspapers, radio channels) had potential to raise awareness 
and promote attendance at screening, whereas lack of media attention could contribute to low 
attendance27.  
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Theme: Stigma (3 studies) 
Some people with diabetes spoke of social stigma or shame being attached to a diabetes 
diagnosis39,43. HCPs also spoke about the difficulties of being confronted by a persons 
perceptions of stigma44.  
 
Knowledge (Total = 35 studies) 
Theme: (Lack of) Awareness of illness (19 studies) 
Several studies reported that a lack of knowledge about diabetes, diabetic retinopathy and the 
link between the two was a barrier to attendance. Understanding of how diabetes can affect 
vision was an essential and motivating factor associated with attendance: “If I had realised the 
possibility that I would suddenly go (blind), that I wouldn’t realise that it was coming on, I 
think I would have taken more care.”45. There was a significant association between believing 
diabetes could affect vision and attendance42. HCPs argued that some lack understanding of 
the link between diabetes and vision22,46. However, HCPs were not always happy to make the 
link clear, being careful not to alarm their patient: “I would never say to someone that there is 
a possibility that you could go blind from diabetes”45.  
 
Theme: (Lack of) Awareness of screening (17 studies) and confusion between screening and 
routine eye tests (8 studies) 
Lack of awareness of the need to screen (including recommended frequency) was a barrier to 
attendance, and awareness was an enabler: “On the one hand a group of over-65s had very 
little knowledge about why they attend for screening. They know it is important that they go, 
and so they keep the appointments but they did not know … that screening helped to prevent 
blindness”14. In one study, people with diabetes who were not able to explain why diabetic 
retinopathy screening is needed reported more barriers than those who could47. Some were not 
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aware of the difference between retinopathy screening and routine eye tests; hence, some 
believed they had attended screening when they had not23,27,32. 
 
Theme: Education and training (8 studies) 
Receiving diabetes self-management or blindness prevention classes significantly increased 
attendance19,48,49, whilst those who had not received education on diabetes care were screened 
significantly less often than those who had50. 
 
Memory, attention and decision processes (Total 34 studies) 
Theme: Symptoms (24 studies) 
The absence of symptoms often resulted in people with diabetes deciding not to attend 
screening14,22,37,43,51. This barrier was evident across different countries and screening contexts 
(e.g. UK, USA, Africa, Asia, and Australia) and may be especially relevant for men13. 
However, even when symptoms were experienced some did not always link these to diabetic 
retinopathy but to an inevitable consequence of getting older37. 
 
Theme: Competing health problems (13 studies) 
Many people with diabetes experience competing health problems that can overshadow 
concerns with their eyes. For some, missing a screening appointment might be due to a 
temporary illness or health problem23,24,27 but for others it was a consequence of 
comorbidities25,42,52 or the burden of diabetes17,29,39. 
 
Theme: Forgetting (10 studies) 
For some people with diabetes, failure to attend screening was attributed to: forgetting to make 
an appointment25; forgetting to attend24,26,53; or forgetting whether they had previously 
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attended14. Several studies alluded to HCPs’ attempts to prompt or remind their patients in 
advance of their upcoming appointment14,27 and some reported that reminders prompted them 
to maintain regular attendance43. 
 
Theme: People with diabetes perception that they have been checked elsewhere (5 studies) 
Sometimes people believed they had been or were going to be checked elsewhere because they 
were transferring their eye care to another specialist53, or their eyes had already been examined 
by a family physician or as part of routine eye test by an optician27,36. 
 
Theme: Knowing it’s a routine test (3 studies) 
An enabler was expecting screening to be part of their routine care30,31,54. 
 
Beliefs about consequences (Total = 26 studies) 
Theme: Perceived necessity of screening (13 studies) and screening provides valuable 
information on the health status of your eyes (7 studies) 
Some people with diabetes do not attend as they believe it is unnecessary32,42,55 ‘I was told that 
my eyes are fine at my last screening’14,25, ‘my diabetes is under control’13,37,46 and ‘screening 
is not useful at my age’29,33. However, others reported that screening will identify problems 
early and this was motivating27,54,56,57. Some reported that screening can provide reassurance 
that all is well22,27,56 or that they attended screening as family members had experienced 
problems with diabetes or retinopathy in the past27,30.  
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Themes: Short-term effects of screening (11 studies) and concerns about the harmful effect of 
the screening procedure (4 studies) 
Some people with diabetes reported that screening has negative short-term effects, for example, 
some dislike mydriatic eye drops (given to temporarily dilate the pupils)31,54,58, which were 
often uncomfortable or, in some cases, painful27,29,37. In one case a woman had developed a 
phobia of these eye drops24. 
 
Mydriatic drops were also inconvenient due to their temporary effects on vision. Hence, they 
were prohibited from driving until the effects of the drops had worn off or it was difficult to 
navigate public transport27,31. Some reported that screening could have long-term negative 
effects on vision, either from the drops or from the retinal photographs23,59. 
 
Emotions (Total = 23 studies) 
Theme: Fear or anxiety (20 studies) 
For some, the fear of losing their vision was a strong incentive to attend screening14,26,31. 
However for others, fear of a diagnosis of diabetic retinopathy was a barrier45,57,60. or fear of 
the screening procedure itself24,29,47 or of a medical intervention if they were confronted with a 
diagnosis29,41,61. In one study, non-adherent participants expressed less concern about losing 
their vision than adherent participants62. 
 
Theme: Defensive responses 
Defensive responses were sometimes noted. In one study young adults who participated in their 
study reported that they wanted to attend screening, but actively engaged in avoidance 
strategies56. In other studies people with diabetes simply refused to attend, without 
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explanation13,24,46: “[the patient] is refusing to even discuss his condition, so all you can do is 
keep sending invites”24.  
 
Theme: Emotional burden of diabetes 
For some, attending screening appointments could exacerbate negative emotions relating to 
lack of control of their diabetes, including feelings of failure, guilt, fear and anger14,26,45. 
 
Details of the domains and the corresponding barriers/enablers that were considered less 
important are provided in supplementary Appendix F 
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Discussion  
We employed a systematic, theory-informed and replicable approach to identifying barriers 
and enablers associated with screening attendance. The combined content and framework 
analysis identified six Theoretical Domains Framework domains as the most influential factors 
in screening attendance: 1) ‘environmental context and resources’, 2) ‘social influences’, 3) 
‘knowledge’, 4) ‘memory, attention and decision processes’ 5), ‘beliefs about consequences’ 
and 6) ‘emotions’. Interventions that target these domains may be more likely to increase 
screening attendance. In contrast, three domains seemed to have the least influence on 
screening: 1) ‘optimism’, 2) ‘reinforcement’ and 3) ‘skills’. Hence, we propose that 
interventions targeting these three domains are less likely to increase screening attendance 
(Tables 2 and 3).  
 
Implications for practice  
Thematic synthesis within domains resulted in specific content themes that may help to identify 
potential targets for future QI interventions. The content themes were identified at multiple 
levels, including: the person with diabetes (e.g. confusion between screening and routine eye 
care); the HCP (e.g. recommendation to screen, or lack of such recommendation, by HCP); the 
healthcare system (e.g. inaccurate registers) and the wider community (e.g. lack of media 
coverage) (supplementary Appendix F).  
 
Four key recommendations based on the findings from the thematic synthesis are: (i) reduce 
inconvenience to people with diabetes; (ii) increase awareness of the importance of screening; 
(iii) increase a sense of comfort and support; and (iv) improve message content.  
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i). Reduce inconvenience to people with diabetes 
Many of the barriers/ enablers identified relate to perceptions of convenience. Difficulties with 
transportation, distance to the screening clinic, competing health and time demands, lack of 
instrumental/pragmatic support and scheduling appointment issues were reported to be 
important factors that may hinder attendance, whereas attempts to reduce inconvenience by 
improving accessibility, flexible appointments and integrating services were reported to 
facilitate attendance. Therefore, providing local screening facilities, ‘one-stop shops’ 
(integrating screening with other DM appointments), offering flexible appointment systems 
and childcare facilities, and providing transportation may be advantageous. 
ii). Increase awareness of the importance of screening  
Both people with diabetes and HCPs reported that a lack of awareness or understanding of 
diabetic retinopathy, DM and the link between the two was a barrier to attendance. Similarly, 
a lack of awareness of the importance of screening, the recommended frequency or a lack of 
targeted education were also reported to be barriers for people with diabetes, whereas providing 
blindness prevention programs or general diabetes self-management education was reported to 
be an enabler. The perceived absence of a HCP recommendation to attend screening and/or a 
lack of information provision from the HCP were also perceived barriers and therefore 
facilitating HCPs to provide such recommendations could potentially address this barrier. 
Similarly, using the local media and local community networks to improve awareness and 
promote attendance was reported as a potential but often untapped resource. 
iii). Increase people with diabetes sense of comfort and support 
Some reported barriers relating to difficulties with: communicating with HCPs, a lack of trust 
in doctors, a lack of emotional support, and negative emotions (e.g. fear, worry). Although 
there were limited reports of potential enablers to overcome such barriers, there was some 
mention that: community-based clinics; social/cultural compatibility between the person with 
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diabetes and HCPs; and compassion from the HCP were enablers which might encourage  
feelings of comfort, support and trust. There is some evidence for additional benefits of using 
culturally competent interventions that are tailored to the needs of people from ethnic minority 
groups for improving diabetes-related outcomes63. 
iv). Improve message content 
The absence of symptoms was a commonly-mentioned barrier to attendance. Furthermore, 
some people with diabetes perceived that screening was not necessary, especially if they felt 
their diabetes was under control, they were not old, or if their previous test result was clear. 
Therefore, it would seem desirable to provide messages that highlight the asymptomatic nature 
of diabetic retinopathy and make salient the potential consequences if left unchecked. Likewise 
providing messages that emphasise and highlight the benefits of early detection, the safety of 
the procedure and the reassurance a positive result can provide would be recommended and 
help in part overcome barriers around emotional fears and concerns. In addition, a barrier 
related to the confusion between attendance at diabetic retinopathy screening and routine eye 
tests. Messages highlighting the difference between the two and emphasising the importance 
of continuing to attend despite attendance at other eye tests could be helpful. Furthermore, 
messages that emphasise that retinopathy screening is a routine part of diabetes care are also 
recommended as this belief was identified as an enabler. The offer of a reminder to attend DR 
screening was also regarded as an enabler addressing this domain. 
 
Recommendations for future research 
Identifying disparities in adherence to screening was not an objective of the current review and 
therefore it is not possible to recommend which sub-groups/populations require the greatest 
attention. However, a recent review has summarised the literature from the US and highlighted 
disparities in a number of sub-groups including: males; youth-vs. adult-onset diabetes; specific 
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minority populations; low socioeconomic status64. Future research could endeavour to identify 
which theoretical domains are most important for people within these sub-groups. For example, 
we identified only two studies that explored factors impacting young adults29,56. This  group is 
not only under-researched but also at high risk of vision loss/blindness from diabetic 
retinopathy. In one of these studies, Lake et al29  compared the barriers and enablers of young 
adults with type 2 diabetes (18-39 year) with a group of older adults with type 2 (40+ years) 
and found that younger adults had a higher number of barriers compared to older adults as well 
as factors that appeared to be highly relevant to younger adults such as ‘social comparison with 
others’, ‘concerns for the impact on the family unit’, ‘unrealistic optimism’ and ‘perceived 
invulnerability’. Such knowledge will allow for future interventions to be tailored to those most 
at risk.  
 
Strengths, limitations and challenges 
The combination of deductive coding (informed by a theoretical framework to guide barrier 
identification) and inductive analysis (to allow more granular content themes, unanticipated 
findings and insights from people with diabetes to emerge) is a strength of this review. 
Furthermore, the review identified potential influence of people with diabetes, HCP, 
organisational and contextual factors on screening attendance. We were able to code all 
extracted data from the 69 studies into theoretical domains, thus demonstrating that the 
framework provides a comprehensive coverage of barriers and enablers.  
 
Another strength was its inclusiveness. We included published and grey literature; qualitative 
and quantitative methodologies; perspectives of people with diabetes and HCPs’; and any 
context and/or screening model. Although not all barriers and enablers will be relevant to all 
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settings, this review gives a comprehensive overview of potential factors that may influence 
screening attendance.  
 
The studies in this review predominantly identified barriers and enablers from the perspective 
of the person with diabetes rather than the perspective of the organisation or HCP. Even the 
data we had from the HCPs mostly focused on their views regarding their patient’s barriers.   
 
A number of the studies were poorly described. This hampered our ability to differentiate 
between the perspectives of the HCP and person with diabetes or to distinguish between 
different sub-groups of people with diabetes. Furthermore, the data extracted and analysed in 
the present review was that which was reported, analysed and interpreted by the study 
authors. It is possible that our data set may have been biased, in that authors may have 
selectively reported findings on perceived barriers/enablers that were more prevalent, 
interesting, or had a better fit with the stated research question. A further limitation is that the 
theoretical framework used is limited in so much as it does not specify relationships between 
domains and hence the likely strength of direct impact of barriers on behaviour is not known. 
 
Although the majority of the screening, data extraction and quality appraisal was carried out 
by a single reviewer, there was excellent agreement on random subset of studies that were 
checked by a second reviewer. Consequently we do not believe that this constitutes a major 
limitation. 
 
Concluding remarks 
Six theoretical domains were identified as the factors most likely to be key mediators of 
retinopathy screening attendance behaviour. Interventions to increase screeningattendance are 
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more likely to be effective if they target these domains. Thematic synthesis identified key 
content themes that offer further insight into which specific issues need to be addressed 
(notably, accessibility of screening clinic, time (competing demands), financial concerns, and 
scheduling appointment issues). Future research is needed to identify which domains are 
most important for sub-groups of people with diabetes that have been identified as most at 
risk.  
TABLE 1. Characteristics of included studies 
Study 
characteristics 
Frequencies (TOTAL N=69 studies) 
Study Methods 
45 (65%) quantitative (e.g. questionnaires, surveys) 
18 (26%) qualitative (e.g. interviews/focus groups) 
6 (9%) mixed methods 
Study Location 
30 (43%) USA. 
13 (19%) UK 
10 (14%) Asia 
6 (9%) Africa 
4 (6%) Australia 
3 (4%) Canada 
2 (3%) Europe 2 
1 (1.5%) South America 
Publication Type 
56 (81%) full-text in peer-reviewed journals 
5 (7%) full-text in unpublished reports/dissertations 
8 (12%) abstracts/posters. 
Perspective of 
Reported 
Barrier/Enabler 
53 (77%) perspective of people with diabetes 
15 (22%) both people with diabetes and HCP perspectives 
 
• n=11 specific ethnic groups (e.g. African Americans; American 
Indians; Aboriginal Canadians; people with South Asian or Hispanic 
origin) 
• n=5 people who were classified as either non- or late- attenders 
• n=3 adults (e.g. 40+) 
• n=2 younger adults 
• n=2 (7%) women only 
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• n= 2  people who had been diagnosed with DR 
• n=1 participant receiving treatment 
• n=1 participants in a blindness prevention programme 
• n=1 Medicare population  
• n=1 people with diabetes who were also hospital staff. 
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TABLE 2. Frequencies (number of themes/sub-themes) of barriers and enablers coded to each of the 
14 domains of the Theoretical Domains Framework. 
Inductive analysis 
 
  
Theoretical Domains Framework 
Domain 
Barriers Only Enablers Only Both barriers 
and enablers 
Environmental context & resources 17 3 6 
Social influences 6 5 5 
Knowledge  4 5 6 
Memory attention & decision processes 9 3 0 
Beliefs about consequences 9 5 0 
Emotions 6 3 1 
Social professional role & identity 5 1 0 
Goals 2 1 1 
Beliefs about capabilities  2 0 0 
Behavioural regulation 0 2 1 
Intention 1 2 0 
Optimism  1 2 0 
Reinforcement 0 3 1 
Skills 0 0 0 
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TABLE 3. Frequency and elaboration within each of the 14 Theoretical Domains Framework 
domains, presented in rank order from most important to least important. 
 
 
Theoretical Domains Framework 
Domain (rank order) 
Frequency Level of elaboration 
No. of 
studies 
identified 
No. 
themes 
No. Sub-
themes 
1. Environmental context & resources 52 11 23 
2. Social influences 35 11 8 
3. Knowledge  35 6 12 
4. Memory attention & decision processes 34 6 9 
5. Beliefs about consequences 26 9 10 
6. Emotions 23 6 6 
7. Goals  13 2 3 
8. Social professional role & identity  11 3 5 
9. Intention 9 2 4 
10. Beliefs about capabilities  9 1 2 
11. Behavioural regulation 7 3 0 
12. Optimism  5 3 0 
13. Reinforcement 3 2 4 
14. Skills 0 0 0 
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FIGURE 1: Flow diagram of steps in the analysis.  
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165 full-text articles excluded 
• Not linked to attendance = 57  
• No barriers/enablers = 31 
• Non-modifiable factors only = 19 
• Not reported in English = 15 
• Reviews/overviews =14 
• Duplicate results = 11 
• Mixed with other patient groups = 5 
• No results = 4 
• Results mixed with other screening = 3 
• Results mixed with other  diabetes 
care = 3 
• No access = 2 
• Authors perspective only = 1 
4,662 records identified through 
database search 
 
 
 
Sc
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g 
In
cl
u
d
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Id
en
ti
fi
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ti
o
n
 
 
223 additional records identified 
through other sources  
 
2,909 records excluded based on 
title and abstract 
 
234 articles assessed for 
eligibility  
 
69 studies included in 
systematic review 
 
FIGURE 2: PRISMA flow diagram. 
3,086 records after duplicates 
removed 
108 records after duplicates 
removed 
 
51 records excluded based on 
title and abstract 
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